期刊文献+

抑肽酶对体外循环中TNF-α与A-aDO_2及出血的影响

下载PDF
导出
摘要 目的:探讨抑肽酶对体外循环(cardiopulmonary bypass,CPB)下冠状动脉旁路移植术(coronary artery bypass,CABG)患者肿瘤坏死因子-α(tumor necrosis factorα,TNF-α)与肺泡动脉氧分压差(A-aDO2)以及术后出血的影响。方法:总结40例CPB下行CABG手术患者,20例体外循环期间使用抑肽酶,另外20例体外循环期间未使用抑肽酶,分别检测计算麻醉诱导诱导前、CPB后转机后2h、24 h TNF-α与A-aDO2,统计患者术后引流量。结果:术后出血量为(417±179)mL和(843±228)mL,但差异无显著性(P>0.05)。两组CPB开始后2 h和24 h TNF-α均有明显升高,非抑肽酶使用组较使用组高,差异有显著性(P<0.05)。两组CPB开始后2 h和24 h A-aDO2均有明显升高,差异无显著性(P>0.05)。结论:停止使用抑肽酶后,伴随CPB手术的TNF-α的释放会有所增加,但这种增加并不足以增加对器官功能的损害;停止应用抑肽酶不会引起CPB术后出血的显著增加。
出处 《温州医学院学报》 CAS 2010年第6期589-591,共3页 Journal of Wenzhou Medical College
  • 相关文献

参考文献5

  • 1De Vroege R,Te Meerman F,Eijsman L,et al.Induction and detection of disturbed homeostasis in cardiopulmonary bypass[J].Perfusion,2004,19(5):267-276.
  • 2Engles L.Review and application of serine protease inhibition in coronary artery bypass graft surgery[J].Am J Health Syst Pharm,2005,62(18 Suppl 4):S9-14.
  • 3Mangano DT,Tudor IC,Dietzel C,et al.The risk associated with aprotinin in cardiac surgery[J].N Engl J Med,2006,354(4):353-365.
  • 4赵举(综述),龙村(审校).心脏直视手术后的全身炎症反应综合征与机体免疫应答[J].中国体外循环杂志,2009,7(1):62-64. 被引量:8
  • 5Sedrakyan A,Wu A,Sedrakyan G,et al.Aprotinin use in thoracic aortic surgery:safety and outcomes[J].J Thorac Cardiovasc Surg,2006,132(4):909-917.

二级参考文献15

  • 1Rothenburger M,Tjan TD,Schneider M,et al.The impact of the pro-and anti-inflammatory immune response on ventilation time after cardiac surgery[J].Cytometry B Clin Cytom,2003,53(1):70-74.
  • 2Lequier L.Extracorporeal life support in pediatric and neonatal critical care:a review[J].J Intensive Care Med,2004,19(5):243-258.
  • 3Markewitz A,Lante W,Franke A,et al.Alterations of cell-mediated immunity following cardiac operations:clinical implications and open questions[J].Shock,2001,16 Suppl 1:10-15.
  • 4Jensen E,Andreasson S,Bengtsson A,et al.Influence of two different perfusion systems on inflammatory response in pediatric heart surgery[J].Ann Thorac Surg,2003,75(3):919-925.
  • 5Harig F,Feyrer R,Mahmoud FO,et al.Reducing the post-pump syndrome by using heparin-coated circuits,steroids,or aprotinin[J].Thorac Cardiovasc Surg,1999,47(2):111-118.
  • 6Harig F,Hohenstein B,von der Emde J,et al.Modulating IL-6 and IL-10 levels by pharmacologic strategies and the impact of different Cardiopulmonary bypass parameters during cardiac surgery[J].Shock,2001,16 Suppl 1:33-38.
  • 7Inui K,Shimazaki Y,Watanade T,et al.Effects of Duraflo II heparin-coated cardiopulmonary bypass circuits on the coagulation system,endothelial damage,and cytokine release in patients with cardiac operation employing aprotinin and steroids[J].Artif Organs,1999,23(12):1107-1112.
  • 8Tayama E,Hayashida N,Fukunaga S,et al.High-dose cimetidine reduces proinflammatory reaction after cardiac surgery with cardiopulmonary bypass[J].Ann Thorac Surg,2001,72(6):1945-1949.
  • 9Rinder CS,Fontes M,Mathew JP,et al.Neutrophil CD11b upregulation during cardiopulmonary bypass is associated with postoperative renal injury[J].Ann Thorac Surg,2003,75(3):899-905.
  • 10Massoudy P,Zahler S,Becker BF,et al.Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass[J].Chest,2001,119(1):31-36.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部